The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various services and units from both the Hospital Clínic Barcelo...
Read moreEl Instituto de Investigación Sanitaria INCLIVA ha puesto en marcha un ensayo clínico sobre salud ósea de pacientes de cáncer de mama, en el marco del proyecto europeo REBECCA.
Read moreMineralys Therapeutics today announced the first patient dosed in the ADVANCE-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN...
Read moreEl Instituto de Investigación del Hospital de la Santa Creu i Sant Pau – IIB Sant Pau ha desarrollado un nuevo medicamento de inmunoterapia CAR-T que acaba de empezar a administrar, en el marco de ...
Read moreLa evidencia de este estudio pionero refuerza la idoneidad de apostar por la preservación de la fertilidad antes de iniciar el tratamiento oncológico y abre la posibilidad de un embarazo seguro para...
Read moreA phase III clinical trial comparing the efficacy the combination of Trifluridine/tipiracil plus the antibody bevacizumab versus Trifluridine/tipiracil in patients with refractory metastatic colonrect...
Read moreFPWR’s philanthropic investment will be used to partially fund Palobiofarma’s ongoing Phase 2 clinical trial to develop PBF-999 for the treatment of Prader Willi syndrome (PWS).
Read moreHan participado en un documento de consenso mundial sobre recomendaciones para llevar a cabo ensayos clínicos de fase temprana con combinaciones de fármacos para el tratamiento del cáncer pediátri...
Read moreAlmirall ha anunciado recientemente los resultados de un análisis secundario del programa en fase III (estudios ADvocate y ADhere) que ha demostrado que los pacientes tratados con lebrikizumab mejora...
Read moreOryzon Genomics, S.A. a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first ...
Read morePalobiofarma S.L., a biopharmaceutical company dedicated to the discovery and development of innovative drugs, has enrolled the first three patients in a clinical study to investigate the potential of...
Read moreOryzon today announced the presentation of the trial in progress (TIP) FRIDA poster entitled Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myelo...
Read more